Skip to content

Z+PHARMA

Active
Public limited companyfounded 1994active for 32 yearsStatiestraat 131, 2070 Beveren-Kruibeke-Zwijndrecht, BelgiumKBO/BCE: BE 0453.060.967
Summary

Z+PHARMA has been active since 1994 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €508,048 and a net result of -€13,886. Equity is growing by about 4% per year across the filed financial years. Its solvency ranks better than 79% of 329 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
Z+PHARMAActiveChecked score 88/100
Risk analysis ReportCompare

History

On 1 July 1994, Z+PHARMA was incorporated.1 Total assets went from €1.3m in 2018 to €746,039 in 2026 and headcount from 3.2 to 4.9 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2026

Acts, filings and financial milestones

Next filing, financial year 2027, expected by 31-10-2027
2026
21-09
NBB filing Annual accounts filed
financial year 2026 · full format
31-03
Financial Weakest financial yearnet -€13,886
Net result drops to -€13,886, the lowest in the series.
2025
24-09
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2024
06-12
Gazette deed Appointment: EY Bedrijfsrevisoren (statutory auditor)
Permanent representative: Emilie VAN CALLEMONT · Capital · Power of attorney8 facts ▸
  • General meeting, 26-06-2024
  • Auditor appointment, EY Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Emilie VAN CALLEMONT
  • General meeting, 28-06-2024
  • Other provision, “verslaggeving-omzetting-vrijstelling-voorlezing, EERSTE BESLISSING-Verslaggeving” (deed in Dutch)
  • Capital, €61,500
  • Power of attorney, Willem Muyshondt
  • Power of attorney
18-11
Gazette deed Appointment: EY Bedrijfsrevisoren (statutory auditor)
Permanent representative: Emilie VAN CALLEMONT3 facts ▸
  • General meeting, 26-06-2024
  • Auditor appointment, EY Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Emilie VAN CALLEMONT
29-10
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
10-05
Gazette deed Amendment of the articles · Legal-form change
Capital conversion · Kind of shares · Power of attorney10 facts ▸
  • General meeting
  • Other provision, “overgangsbepaling lopend boekjaar”, 31-03-2024 (deed in Dutch)
  • General meeting, 13.30, “derde dinsdag van september 2024” (deed in Dutch)
  • Other provision, “aanpassing statuten aan WVV en behoud rechtsvorm, artikel 39,§1,eerste en derde lid wet 23-03-2019” (deed in Dutch)
  • Capital conversion, “artikel 39,§2,tweede lid wet 23-03-2019, eigen vermogensrekening niet-opgevraagde inbrengen” (deed in Dutch)
  • Capital conversion, “opheffing statutair onbeschikbare eigen vermogensrekening, beschikbaar voor uitkering” (deed in Dutch)
  • Amendment of the articles
  • Kind of shares, “vergoeding voor de inbrengen”, 750 (deed in Dutch)
  • Power of attorney
  • Registered office clause, “Statiestraat 131”, 2070 (deed in Dutch)
31-03
Financial Highest result from 2018 to 2026net €195,315 ▲196%
Operating result €299,642, net result €195,315, both a record.
31-03
Financial Liquidity more than triplescurrent ratio 3.43
Current ratio from 1.07 to 3.43; short-term debt falls from €513,567 to €183,011.
31-03
Financial Equity above €500,000equity €644,984 ▲45.4%
A profit in every financial year since 2018 builds equity to €644,984.
2023
18-08
Gazette deed Resignation: COSIFARMA (director)
Permanent representatives: Björn Simons and Karla Colpin · Appointments: Jef Colruyt, Stefaan Vandamme and 3 others9 facts ▸
  • General meeting, 31-05-2023
  • Director resignation, COSIFARMA (director)
  • Permanent representative, Björn Simons
  • Permanent representative, Karla Colpin
  • Director appointment, Jef Colruyt (director)
  • Director appointment, Stefaan Vandamme (director)
  • Director appointment, Kris Castelein (director)
  • Director appointment, Jo Willemyris (director)
  • Director appointment, Stefan Goethaert (director)
26-05
NBB filing Annual accounts filed
financial year 2022 · abbreviated format
Show earlier events
2022
30-05
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
2021
05-08
NBB filing Annual accounts filed
financial year 2020 · abbreviated format · 5 days late
2020
28-05
NBB filing Annual accounts filed
financial year 2019 · abbreviated format
2019
06-08
NBB filing Annual accounts filed
financial year 2018 · abbreviated format · 6 days late
2018
26-07
NBB filing Annual accounts filed
financial year 2017 · abbreviated format
2017
29-08
NBB filing Annual accounts filed
financial year 2016 · abbreviated format · 29 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 31 annual accounts filed, the latest 10 are here; all 31 are under Financials.
4 of 6 deeds read
About the unread acts

Of the 6 Belgian Official Gazette deeds we know for this company, 4 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure